Profusa, Inc. Common Stock (PFSA) 10-Year Financial Performance & Capital Metrics

PFSA • • Industrial / General

HealthcareMedical EquipmentDiabetes Management & MonitoringContinuous Glucose Monitoring Biosensors

AboutA digital-health company developing tissue-integrating biosensors (e.g. the Lumee™ Oxygen Platform) to continuously monitor body chemistry and provide AI-powered health insights, targeting chronic conditions such as diabetes and critical limb ischemiaShow more

Revenue $0
EBITDA -$5M +19.9%
Net Income -$9M +10.2%
EPS (Diluted) -0.28 +9.7%
Gross Margin -
EBITDA Margin -
Operating Margin -
Net Margin -
ROE -
ROIC -
Debt/Equity -
Interest Coverage -1.02 +28.2%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

✗Weak momentum: RS Rating 11 (bottom 11%)
✗Low quality earnings: Net income not backed by cash flow
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-706.78%

EPS CAGR

10Y-

5Y-

3Y-

TTM-73.91%

ROCE

10Y Avg-

5Y Avg-

3Y Avg-

Latest-

Peer Comparison

Continuous Glucose Monitoring Biosensors

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PFSAProfusa, Inc. Common Stock	8.56M	0.10	-0.35

Profit & Loss

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	0	0	0
Revenue Growth %	-	-	-	-
Cost of Goods Sold+	0	0	0	0
COGS % of Revenue	-	-	-	-
Gross Profit+	0	0	0	0
Gross Margin %	-	-	-	-
Gross Profit Growth %	-	-	-	-
Operating Expenses+	11.69M	11.14M	6.07M	4.5M
OpEx % of Revenue	-	-	-	-
Selling, General & Admin	4.77M	5.24M	4.08M	2.99M
SG&A % of Revenue	-	-	-	-
Research & Development	7.66M	4.2M	2.04M	1.61M
R&D % of Revenue	-	-	-	-
Other Operating Expenses	-742K	1.7M	-45K	-100K
Operating Income+	-11.69M	-11.14M	-6.07M	-4.5M
Operating Margin %	-	-	-	-
Operating Income Growth %	-	0.05%	0.46%	0.26%
EBITDA+	-10.51M	-10.42M	-6M	-4.81M
EBITDA Margin %	-	-	-	-
EBITDA Growth %	-	0.01%	0.42%	0.2%
D&A (Non-Cash Add-back)	1.18M	724K	0	0
EBIT	-6.23M	-13.95M	-6M	-4.81M
Net Interest Income+	-4.08M	-6.27M	-4.28M	-4.42M
Interest Income	0	0	0	0
Interest Expense	4.08M	6.27M	4.28M	4.42M
Other Income/Expense	1.38M	-9.08M	-4.21M	-4.73M
Pretax Income+	-10.31M	-20.22M	-10.28M	-9.23M
Pretax Margin %	-	-	-	-
Income Tax+	0	0	0	0
Effective Tax Rate %	1%	1%	1%	1%
Net Income+	-10.31M	-20.22M	-10.28M	-9.23M
Net Margin %	-	-	-	-
Net Income Growth %	-	-0.96%	0.49%	0.1%
Net Income (Continuing)	-10.31M	-20.22M	-10.28M	-9.23M
Discontinued Operations	0	0	0	0
Minority Interest	0	0	0	0
EPS (Diluted)+	-0.31	-0.62	-0.31	-0.28
EPS Growth %	-	-1%	0.5%	0.1%
EPS (Basic)	-0.31	-0.62	-0.31	-0.28
Diluted Shares Outstanding	32.79M	32.79M	32.79M	32.79M
Basic Shares Outstanding	32.79M	32.79M	32.79M	32.79M
Dividend Payout Ratio	-	-	-	-

Balance Sheet

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	958K	160K	333K	260K
Cash & Short-Term Investments	856K	78K	142K	191K
Cash Only	856K	78K	142K	191K
Short-Term Investments	0	0	0	0
Accounts Receivable	38K	0	45K	0
Days Sales Outstanding	-	-	-	-
Inventory	0	0	0	0
Days Inventory Outstanding	-	-	-	-
Other Current Assets	64K	82K	0	0
Total Non-Current Assets+	10.4M	871K	1.56M	2.81M
Property, Plant & Equipment	10.11M	0	2K	0
Fixed Asset Turnover	-	-	-	-
Goodwill	0	0	0	0
Intangible Assets	0	0	0	0
Long-Term Investments	0	0	0	0
Other Non-Current Assets	293K	871K	1.56M	2.81M
Total Assets+	11.36M	1.03M	1.89M	3.07M
Asset Turnover	-	-	-	-
Asset Growth %	-	-0.91%	0.84%	0.62%
Total Current Liabilities+	21.61M	35.65M	46.74M	57.13M
Accounts Payable	3.26M	3.43M	3.99M	4.95M
Days Payables Outstanding	-	-	-	-
Short-Term Debt	15.01M	31.03M	40.4M	48.21M
Deferred Revenue (Current)	0	0	0	0
Other Current Liabilities	2.42M	584K	1.96M	3.47M
Current Ratio	0.04x	0.00x	0.01x	0.00x
Quick Ratio	0.04x	0.00x	0.01x	0.00x
Cash Conversion Cycle	-	-	-	-
Total Non-Current Liabilities+	73.41M	65.15M	65.15M	65.15M
Long-Term Debt	1.19M	0	0	0
Capital Lease Obligations	7.07M	0	0	0
Deferred Tax Liabilities	0	0	0	0
Other Non-Current Liabilities	65.15M	65.15M	65.15M	65.15M
Total Liabilities	95.02M	100.8M	111.89M	122.28M
Total Debt+	24.02M	31.03M	40.4M	48.21M
Net Debt	23.16M	30.95M	40.25M	48.02M
Debt / Equity	-	-	-	-
Debt / EBITDA	-	-	-	-
Net Debt / EBITDA	-	-	-	-
Interest Coverage	-2.87x	-1.78x	-1.42x	-1.02x
Total Equity+	-83.66M	-99.77M	-110M	-119.2M
Equity Growth %	-	-0.19%	-0.1%	-0.08%
Book Value per Share	-2.55	-3.04	-3.35	-3.64
Total Shareholders' Equity	-83.66M	-99.77M	-110M	-119.2M
Common Stock	0	0	0	0
Retained Earnings	-85.23M	-105.45M	-115.73M	-124.96M
Treasury Stock	0	0	0	0
Accumulated OCI	0	0	0	0
Minority Interest	0	0	0	0

Cash Flow

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-10.69M	-7.7M	-4.4M	-2.07M
Operating CF Margin %	-	-	-	-
Operating CF Growth %	-	0.28%	0.43%	0.53%
Net Income	-10.31M	-20.22M	-10.28M	-9.23M
Depreciation & Amortization	1.18M	724K	0	0
Stock-Based Compensation	72K	111K	33K	21K
Deferred Taxes	0	0	0	0
Other Non-Cash Items	-1.11M	10.77M	4.3M	4.74M
Working Capital Changes	-522K	909K	1.54M	2.41M
Change in Receivables	371K	38K	-45K	45K
Change in Inventory	0	0	0	0
Change in Payables	-60K	706K	533K	645K
Cash from Investing+	0	0	-2K	0
Capital Expenditures	0	0	-2K	0
CapEx % of Revenue	-	-	-	-
Acquisitions	-	-	-	-
Investments	-	-	-	-
Other Investing	0	0	0	0
Cash from Financing+	8.75M	6.92M	4.47M	2.12M
Debt Issued (Net)	-	-	-	-
Equity Issued (Net)	-	-	-	-
Dividends Paid	0	0	0	0
Share Repurchases	-	-	-	-
Other Financing	51K	-772K	-591K	-961K
Net Change in Cash	-	-	-	-
Free Cash Flow+	-10.69M	-7.7M	-4.4M	-2.07M
FCF Margin %	-	-	-	-
FCF Growth %	-	0.28%	0.43%	0.53%
FCF per Share	-0.33	-0.23	-0.13	-0.06
FCF Conversion (FCF/Net Income)	1.04x	0.38x	0.43x	0.22x
Interest Paid	0	0	0	0
Taxes Paid	0	0	0	0

Key Ratios

Metric	2021	2022	2023	2024
Interest Coverage	-2.87x	-1.78x	-1.42x	-1.02x
FCF Conversion	1.04x	0.38x	0.43x	0.22x

Frequently Asked Questions

Growth & Financials

Profusa, Inc. Common Stock (PFSA) grew revenue by 0.0% over the past year. Growth has been modest.

Profusa, Inc. Common Stock (PFSA) reported a net loss of $40.7M for fiscal year 2024.

Dividend & Returns

Profusa, Inc. Common Stock (PFSA) had negative free cash flow of $11.6M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener